Evidence map›Paper›PMID 17349582›Full record

ArticleCancer cell2007

In vivo-restricted and reversible malignancy induced by human herpesvirus-8 KSHV: a cell and animal model of virally induced Kaposi's sarcoma.

Agata D'Agostino Mutlu, Lucas E Cavallin, Loïc Vincent, Chiara Chiozzini, Pilar Eroles, Elda M Duran, Zahra Asgari, Andrea T Hooper, Krista M D La Perle, Chelsey Hilsher and 4 more

Erratum issuedOpen access · bronzeAbstract read
In one paragraph

Article in Cancer cell, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 106 papers.

0numbers the graph read from it
0cells of the map it votes in
106citing papers in PubMed
6.9field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

106 citing papers in PubMed, 165 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Review
  5. Animal models of human herpesvirus infection.Animal models and experimental medicine · 2025
    Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Review
  17. Kaposi Sarcoma, a Trifecta of Pathogenic Mechanisms.Diagnostics (Basel, Switzerland) · 2022
    Review
  18. Article
  19. Article
  20. Article

46 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

  • Erratum issued
5 · Who and what money

Authors and funding

14 authors at 4 institutions in 1 country.

Agata D'Agostino MutluLaboratory of Viral Oncogenesis, Division of Hematology-Oncology, Department of Medicine, Weill Medical College of Cornell University, New York, NY 10021, USA.
Lucas E Cavallin
Loïc Vincent
Chiara Chiozzini
Pilar Eroles
Elda M Duran
Zahra Asgari
Andrea T Hooper
Krista M D La Perle
Chelsey Hilsher
Shou-Jiang Gao
Dirk P Dittmer
Shahin Rafii
Enrique A Mesri
Cornell University · USUniversity of Miami · USHoward Hughes Medical Institute · USCancer Research Institute · US

Funding

Cell Model for KSHV Infection and Genetic ManipulationR01CA096512 · NCI · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI Shou-Jiang Gao · 2003 to 2026
$7.4M
ART Modulation of Viral Pathogenesis in Oral EpitheliaR01DE018304 · NIDCR · UNIV OF NORTH CAROLINA CHAPEL HILL · PI DITTMER, DIRK P · 2007 to 2025
$6.9M
Targeted Therapies for HIV-Associated Kaposi Sarcoma and LymphomaR01CA163217 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI BLOSSOM A DAMANIA, Dirk P Dittmer · 2011 to 2026
$5.5M
Regulation of KSHV replication by N6-methyladenosine (m6A) - Diversity SupplementR01CA124332 · NCI · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI GAO, SHOU-JIANG · 2007 to 2025
$5.0M
Mechanism of KSHV-induced angiogenesisR01CA132637 · NCI · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI GAO, SHOU-JIANG · 2008 to 2020
$3.6M
BIOLOGY OF KSHV/HHV8 G PROTEIN COUPLED RECEPTORR01CA075918 · NCI · WEILL MEDICAL COLLEGE OF CORNELL UNIV · PI MESRI, ENRIQUE A · 1998 to 2009
$2.9M
Regulation of the KSHV Latent PromoterR01CA109232 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI DITTMER, DIRK P · 2004 to 2014
$2.5M
In situ real-time PCR arrays for viral-associated canc*R03CA110136 · NCI · UNIVERSITY OF NORTH CAROLINA CHAPEL HILL · PI DITTMER, DIRK P · 2004 to 2005
$139k
NCI NIH HHS CA075918NCI NIH HHS CA096512NCI NIH HHS CA109232NCI NIH HHS CA110136NCI NIH HHS R01 CA075918NCI NIH HHS R01 CA096512NCI NIH HHS R01 CA109232NCI NIH HHS R01 CA124332NCI NIH HHS R01 CA132637NCI NIH HHS R01 CA163217NCI NIH HHS R03 CA110136NIDCR NIH HHS R01 DE018304
6 · The paper itself

Abstract

Transfection of a Kaposi's sarcoma (KS) herpesvirus (KSHV) Bacterial Artificial Chromosome (KSHVBac36) into mouse bone marrow endothelial-lineage cells generates a cell (mECK36) that forms KS-like tumors in mice. mECK36 expressed most KSHV genes and were angiogenic, but they didn't form colonies in soft agar. In nude mice, mECK36 formed KSHV-harboring vascularized spindle cell sarcomas that were LANA+/podoplanin+, overexpressed VEGF and Angiopoietin ligands and receptors, and displayed KSHV and host transcriptomes reminiscent of KS. mECK36 that lost the KSHV episome reverted to nontumorigenicity. siRNA suppression of KSHV vGPCR, an angiogenic gene upregulated in mECK36 tumors, inhibited angiogenicity and tumorigenicity. These results show that KSHV malignancy is in vivo growth restricted and reversible, defining mECK36 as a biologically sensitive animal model of KSHV-dependent KS.

Indexed as

Disease Models, AnimalHerpesvirus 8, HumanAngiopoietinsAnimalsAntigens, ViralBone Marrow CellsCell LineageCells, CulturedCell Transformation, NeoplasticCell Transformation, ViralChromosomes, Artificial, BacterialEndothelial CellsHumansMembrane GlycoproteinsMiceMice, NudeAngiopoietinsAntigens, Virallatency-associated nuclear antigenMembrane GlycoproteinsNuclear ProteinsPdpn protein, mousePodoplaninVascular Endothelial Growth Factor Avascular endothelial growth factor A, mouse

Identifiers

PMID17349582
PMCPMC2180156
OpenAlexW1978855492

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.